Treatment News

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News


April 30, 2014
HIV Raises Melanoma Risk
People living with HIV are at increased risk of melanoma irrespective of antiretroviral use, especially if they are white skinned.
April 29, 2014
Amped Screening Detects Both Acute & Late-Presenting HIV Cases
Ramping up HIV screening programs in hospitals detects more "late presenters" who have long lived with HIV as well as acute cases of the virus.
April 28, 2014
HPV Vaccine Works Well in HIV-Positive Women
HIV-Positive women respond well to the human papillomavirus (HPV) vaccine, even when they have a low CD4 count.
April 25, 2014
HIV Fight Should Target Specific Hard-Hit Neighborhoods
Efforts to fight HIV incidence and mortality should be tailored to the disease’s disproportionate impact on specific urban neighborhoods.
April 24, 2014
FDA Accepts New Applications for Cobicistat and Elvitegravir
The FDA has accepted Gilead Sciences’ resubmitted applications for the approval of cobicistat and elvitegravir to treat HIV.
April 22, 2014
BMS Files for FDA Approval of Reyataz/Cobicistat Combo Pill
Bristol-Myers Squibb has filed a new drug application to the FDA for a fixed-dose combination tablet of Reyataz and cobicistat for HIV treatment.
AbbVie Files for FDA Approval of '3D' Hepatitis C Regimen
AbbVie submitted a new drug application to the FDA for its “3D” combination regimen of antivirals to treat adults with genotype 1 of hepatitis C.
April 21, 2014
Early Data Suggests Many With HIV Accessed Obamacare
A significant proportion of those accessing marketplace insurance plans through Obamacare are people with HIV, according to a study from a major pharmacy benefits manager.
April 18, 2014
Global HIV Incidence Is High in Both Pregnant and New Moms
Global rates of new HIV cases are high among pregnant women and new mothers, putting their children at high risk of mother-to-child transmission.
April 17, 2014
Treating HIV Very Early May Limit Inflammation, Gut Damage
Staring HIV therapy immediately after infection may both limit the virus’s toll on the gut lining and also lower the body’s overall chronic inflammatory state.
April 16, 2014
Favoring ARVs for HIV Subgroups May Better Thwart Epidemic
In the absence of universal treatment, prioritizing HIV meds for specific high-risk subgroups may have a greater effect on curbing the epidemic.
Viral Hepatitis Kills More Europeans Than HIV by Tenfold
European Union citizens die as a result of viral hepatitis at a rate about 10 times greater than deaths related to HIV.
April 15, 2014
HIV Still Found in Semen of Some Fully Suppressed Men
Despite an undetectable plasma viral load, HIV may be intermittently present in men’s semen, with fluctuations occurring in the course of only an hour.
Perfect HIV/HCV Coinfection Cure Rate for Sovaldi/Ledipasvir
A fixed-dose combo pill of Sovaldi and ledipasvir is poised to boast a 100 percent success rate in curing hepatitis C among those coinfected with HIV.
April 14, 2014
Transplant Drugs May Fight HIV Reservoir
Immunosuppressant drugs used to prevent rejction of transplanted organs may combat the HIV reservoir.
April 10, 2014
HIV Prevention Interventions: A Big Turnoff for Youths?
The design of multi-session HIV prevention interventions targeting young people may ultimately prove alienating to that demographic.
April 09, 2014
HIV and Opioid Epidemics Chart Similar Paths
The U.S. opioid addiction epidemic bares key similarities to the HIV epidemic, and these parallels can help guide efforts to combat illicit drug use.
April 08, 2014
Benefits of a Lowered HIV Pill Burden and Dosing Schedule
HIV regimens with fewer pills are linked to better adherence and virologic suppression, while adherence is better with once- versus twice-daily regimens.
April 07, 2014
New Kidney Risk Score System May Guide HIV Med Choices
Researchers have developed a scoring system to estimate the five-year risk for developing kidney disease among HIV-positive men.
Federal Agencies Update Action Plan Against Viral Hepatitis
A consortium of federal agencies has announced the release of an updated blueprint for combatting viral hepatitis in the United States.
April 04, 2014
Jails and Prisons Miss Chances to Test for HIV, Link to Care
U.S. correctional systems are missing vital chances to both test inmates for HIV and to link those living with the virus to care upon re-entry into society.
April 03, 2014
High Rates of Cancer-Linked Anal HPV in Gay Men With HIV
HIV-positive men who have sex with men acquire new anal infections with cancer-associated strains of human papillomavirus (HPV) at high rates.
April 02, 2014
HIV Puts Men at Greater Risk of Heart Disease
Men living with HIV are at greater risk of soft plaque buildup in arteries feeding the heart when compared with their uninfected peers.
April 01, 2014
Janssen Files for Approval of Single-Pill Prezista & Cobicistat
Janssen Research & Development has applied to the FDA for approval for a once-daily combo pill of Prezista (darunavir) and Gilead Sciences’ cobicistat.
More Treatment News

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.

Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ



Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    adorableone
    New York
    New York


    oceanblue65
    louisiana
    Louisiana


    jimmy807
    San Antonio
    Texas


    pozsmith1
    East Bay
    California
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Will decriminalizing injection drug use help end the global HIV epidemic?
Yes
No

Survey
PrEP Course

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.